Daniel J. Minion
Partner
Prior to law school, Dan worked as a medicinal chemist at Agouron Pharmaceuticals and obtained a master’s degree in organic chemistry for his synthetic studies on the viridin family of kinase inhibitors.
Related Practices
Related Industries
Experience
Experience
Representative Matters
- Represented Sanofi Genzyme against several generics on patents relating to Cerdelga® for the treatment of Gaucher disease (D. Del.)
- Represented Grünenthal and Abiogen against Antecip in contested proceedings in the U.S. Patent and Trademark Office (USPTO) relating to the use of bisphosphonates for the treatment of chronic pain (PTAB)
- Represented Sanofi against several generics on patents relating to Jevtana® for the treatment of prostate cancer (D. N.J., D. Del., PTAB, Fed. Cir.)
- Represented Sanofi against several generics on patents relating to Multaq® for the treatment of atrial fibrillation (D. Del., Fed. Cir.)
- Represented Novartis against several generics on patents relating to Exelon Patch® for the treatment of Alzheimer’s disease (D. Del.)
- Represented Bone Care and Genzyme against several generics on patents relating to Hectorol® for the treatment of kidney disease (ND Ill., D. Del.)
- Represented Novartis against Mylan on a patent relating to Femara® for the treatment of breast cancer (D. N.J.)
Representative Clients
- Sanofi/Genzyme
- Novartis
Insights
Insights
Credentials
Credentials
Education
- J.D. Benjamin N. Cardozo School of Law 2006
- M.S. Organic Chemistry University of Pittsburgh 2004
- B.S. Chemistry Stanford University 1996
Bar Admissions
- New York
- U.S. Patent and Trademark Office
Court Admissions
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. Court of Appeals for the Federal Circuit
Recognition
Recognition
- Super Lawyers, Rising Star, Intellectual Property Litigation, New York Metro, 2015 – 2017